Uncategorized

  • Presentation and poster at ASCO Gastrointestinal Cancers Symposium

    Isofol is attending the event and will present details in the ongoing global Phase 3 AGENT clinical study (ISO-CC-007) Presentation…

    by
  • Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin

    Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin GOTHENBURG, Sweden, July 15, 2019 – Isofol Medical AB…

    by